Profitable Pharmaceutical Company

MEDICAL DEVICES: Profitable Healthcare Services Company with a Pipeline of Products. 

One of the cheapest and most effective ways that pharmaceutical companies can retain control of their old patents and increase revenues, is to come up with new dosages and new delivery methods for these drugs, thereby qualifying for new, extended patents without having to go through years of expensive clinical testing to develop entirely new drugs.  Curing Capital Inc. is proud to introduce you a healthcare services company that has efficient supply chain management solutions for generic pharmaceuticals. This company is focused on strategic sourcing to delivering niche generic pharmaceuticals to market.

To request a full package on the featured company please fill out the form below

Key Points about this company:

• It maintains a strategic relationship with the largest pharmaceutical distributor in North America.
• No Debt
• Secured lines of credit of $1.5 million each are in place for purchase order financing and factoring.
• Achieved over $3.5 Million in revenue and was profitable in its first year.
• By 2013, revenues are projected to be over $12 million, with a gross profit of more than $3.5 million.

Market:

The United States constitutes the largest market in the world for generic pharmaceuticals, and its aging population represents a key driver for the growth of the global pharmaceuticals and domestic consumer products markets. Patented drugs generating $90 Billion a year in sales will lose patent protection in the next five years.   There is a demand for low cost generic drugs that are safe.  The featured company has a system that helps to extend drug life cycles. Company Has No Debt!!

Competitors:

What sets the Featured Company apart from its competition is the risk diversification and significant return potential through the Company’s R&D focus. Large, vertically integrated industry players engaged in the development, manufacture, marketing, sale and distribution of generic and/or branded specialty pharmaceuticals in various therapeutic categories include Actavis Group, Apotex, Dr. Reddy’s, Glenmark Pharmaceuticals, Jubilant Life Sciences, Mylan, Par Pharmaceutical Companies, Ranbaxy Laboratories, Sandoz (a division of Novartis), Sun Pharmaceutical Industries, Teva Pharmaceutical Industries, Barr Laboratories (a division of Teva), and Watson Pharmaceuticals. Secured lines of credit of $1.5 million each are in place for purchase order financing and factoring

The Management:

The management team is experienced and well qualified to lead the company as it expands, both through natural growth and through planned acquisitions.

Chairman:  served as Chairman of Global Resource Corporation and as CEO of Worldwide Strategic Partners Inc.  Served as an International Lobbyist for the House and Senate for individual international energy clients from 2005 through 2007. Worked as the Deputy to the Mayor of the city of Philadelphia

CEO is a former marketing consultant and CEO of a prominent recruiting firm who bring years of expertise in marketing and customer relations. He is guiding the company towards greater strategic partnerships and is busy expanding the company’s customer base and direct product placement

CFO has years of professional experience in both the public and private markets as CFO, Controller and Audit Manager of various companies. He is responsible for identifying and evaluating acquisition opportunities, as well as financial reporting and transparency, long-range planning, and corporate and strategic development.

The Opportunity:

the Company has raised more than $2,000,000. Now it is seeking $5 to $7 million of investment capital for the acquisition of a pharmaceutical packager/distributor.  For more information on the company please send me an email or give me a call.